Inventor · disambiguated record
Adriana Haimovitz-Friedman
Also filed as: HAIMOVITZ-FRIEDMAN ADRIANA
4 granted patents·1 pending application·2 citations·filing 2015–2024
63Inventor score
Files withMEMORIAL SLOAN KETTERING CANCER CENTER5
Top patents by PatentIndex Score
5 records- 0182US2025144086A1Enhancement of tumor response to chemotherapy by activation of the asmase/ceramide pathway through timed administration of a short-acting anti-angiogenic agentMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2024·Application pending·0 cites
- 0276US12036212B2Enhancement of tumor response to chemotherapy by activation of the asmase/ceramide pathway through timed administration of a short-acting anti-angiogenic agentMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2022·Granted Jul 16, 2024·0 cites·20 claims
- 0374US10413533B2Enhancement of tumor response to chemotherapy by activation of the ASMase/ceramide pathway through timed administration of a short-acting anti-angiogenic agentMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2015·Granted Sep 17, 2019·1 cites·10 claims
- 0471US10478506B2Fucoidan nanogels and methods of their use and manufactureMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2019·Granted Nov 19, 2019·1 cites·20 claims
- 0570US11285137B2Enhancement of tumor response to chemotherapy by activation of the asmase/ceramide pathway through timed administration of a short-acting anti-angiogenic agentMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2019·Granted Mar 29, 2022·0 cites·26 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →